Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
4.000
+0.280 (7.53%)
At close: May 27, 2026, 4:00 PM EDT
4.050
+0.050 (1.25%)
After-hours: May 27, 2026, 7:03 PM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $264.29 million as of May 27, 2026. Its market cap has increased by 250.63% in one year.
Market Cap
264.29M
Enterprise Value
195.37M
1-Year Change
250.63%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $264.29M, a decrease of -67.14%. That is a compound annual growth rate of -18.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 245.79M | 175.93% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 250.83M |
| Anavex Life Sciences | 249.75M |
| Coherus Oncology | 248.34M |
| Foghorn Therapeutics | 247.77M |
| Alector | 245.37M |
| Minerva Neurosciences | 245.06M |
| Orchestra BioMed Holdings | 243.12M |
| Context Therapeutics | 238.89M |